Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Mycobacterium tuberculosis associated morbidity, mortality and drug resistance is a global health issue. The Gene Xpert is used for early diagnosis of TB and simultaneous detection of Rifampicin (RIF) resistance. We aimed to determine situation analysis of clinical TB in tertiary care hospitals of Faisalabad and to find out frequency of TB and drug resistance pattern by Gene Xpert. A total of 220 samples from suspected patients of TB were included in this study and 214 samples were detected as positive by Gene Xpert. Samples were classified on the basis of gender, age group (<30, 30-50 and >50 years), type of sample (sputum and pleural) and number of M. tuberculosis by ct value (cycle threshold). The results of present study showed high positive frequency of TB in male patients and in 30-50 years of age groups by Gene Xpert. High number of M. tuberculosis was found in low and medium category in TB patients. Out of 214 positive TB patients, rifampicin resistance was detected in 16 patients. In conclusion, our study identified that Gene Xpert is an effective approach for diagnosing TB by detection of M. tuberculosis and rifampicin resistance in <2 hours for rapid diagnosis and management of TB.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Evaluation of sample pooling using Xpert Carba-R and Xpert / PCR for screening of carbapenemase-producing and vancomycin-resistant colonization.
Microbiol Spectr
September 2025
Emerging Infectious Diseases Research Laboratory, Samson Assuta Ashdod University Hospital, Ashdod, Israel.
Screening for carbapenemase-producing (CPE) and vancomycin-resistant (VRE) colonization among hospitalized patients is a standard infection control procedure that also guides appropriate antibiotic treatment in healthcare settings. Extensive CPE screening in low-prevalence regions imposes a considerable laboratory workload and substantial costs that can be mitigated through the utilization of pool testing. In this study, we evaluated PCR pooling for the detection of CPE and VRE colonization from rectal swabs collected in our hospital, using the Xpert Carba-R and Xpert assays.
View Article and Find Full Text PDFPredominance of gram-negative multidrug-resistant pathogens causing lower respiratory tract infections among gene X-pert negative presumptive tuberculosis patients in Dar Es Salaam, Tanzania.
Ann Med
December 2025
Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Background: Lower respiratory tract infections (LTRIs) represent a significant global health burden. The clinical presentation of pulmonary tuberculosis (PTB) and other LRTIs often overlap, making it difficult to differentiate based on clinical features only. This study aims to investigate the role of other bacteria pathogens in LRTIs among presumptive TB patients and antibiotic susceptibility patterns for appropriate patient management.
View Article and Find Full Text PDFRegional epidemiologic data call for enhanced attention to Clostridioides difficile infections in Italy: Results from a population-based study.
J Infect Public Health
August 2025
Department of Life Sciences, Health and Health Professions, Link Campus University, Rome, Italy.
Background: Clostridioides difficile (C. difficile) Infection (CDI) is a major public health concern, causing a range of gastrointestinal diseases with increasing global incidence. In Italy, epidemiologic data on Clostridioides difficile CDI, particularly on community-acquired cases, are limited.
View Article and Find Full Text PDFBackground: Blood-based gene signatures offer potential as a near point-of-care tuberculosis (TB) screening tool. We examined the accuracy of the GeneXpert MTB Host Response (Xpert-HR) cartridge to screen for TB in children.
Methods: We enrolled children under 15 years from The Gambia and Uganda being evaluated for pulmonary TB.
Comparison of two polymerase chain reaction assays, DaAn Gene (DaAn Gene 2019-ncov) and Cepheid (Cepheid Xpert Xpress SARS-CoV-2) for Delta and Omicron variants of SARS-CoV-2 detection in Yaoundé, Cameroon.
J Public Health Afr
July 2025
Centre for Research on Emerging and Re-emerging Diseases (CREMER), Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé, Cameroon.
Background: New severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may affect diagnostic test accuracy.
Aim: To evaluate the performance of two reverse transcription-polymerase chain reaction (RT-PCR) assays, DaAn Gene and Cepheid, for detecting Delta and Omicron variants.
Setting: Nasopharyngeal samples were collected in Yaoundé, Cameroon, between October 2021 and December 2022.